Pursuit of tumor-infiltrating lymphocyte immunotherapy speeds up

Mounting evidence of efficacy in metastatic breast cancer and other epithelial tumors is driving clinical and commercial investment in tumor-infiltrating lymphocytes.
Ann Arbor, Michigan, USA.

Search for this author in:

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Biotechnology 37, 969-971 (2019)

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.